Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Geoffrey D. Chisholm"'
Autor:
Miroslav Hanus, Freddie C. Hamdy, Athanasios Kalinteris, Gary G. Koch, Joris Cauquil, Dominique Chopin, Jean Christophe Carraro, Geoffrey D. Chisholm, Josef Marencak, Dieter Hauri, Pierre Teillac, Antoine Perier, Jean Pierre Raynaud, Paul Perrin, Franco Di Silverio, Fernando Calais da Silva
Publikováno v:
The Prostate. 29:231-240
BACKGROUND Controversy regarding the relative efficacy of treatments for the relief of the symptoms of benign prostatic hyperplasia (BPH). METHODS This was a 6-month double-blind randomized equivalence study that compared the effects of a plant extra
Publikováno v:
European Journal of Cancer. 31:2059-2066
Epidermal growth factor is a potential mitogen for many different human tumours. Its effect is mediated via a bispecific receptor (EGFR), the expression of which correlates well with invasive disease. We investigated the modulation of EGFR by cytokin
Autor:
M McIntyre, Geoffrey D. Chisholm, Andrew Jackson, Keith James, Kesavan Esuvaranathan, Anton B. Alexandroff, S. Prescott
Publikováno v:
Journal of Urology. 154:572-575
Purpose: To determine whether BCG therapy could upregulate interleukin-6 (IL-6) production in human transitional cell carcinomas (TCC).Materials and Methods: Immunohistochemistry of tumor biopsies and urinary cytospins and ELISA studies of urine from
Autor:
R. Wild, Margaret Ross, P. Halliday, Geoffrey D. Chisholm, A. Rana, Fouad K. Habib, R. A. Elton
Publikováno v:
European Journal of Cancer. 31:871-875
The present study was undertaken mainly to investigate whether prolactin manipulation combined with maximal androgen blockage improves the effectiveness of treatment in advanced prostatic cancer. The efficacy of oral hydrocortisone as an alternative
Autor:
S. J. Hawkyard, G.C.W. Howard, R.E.S. El-Galley, Gillian R. Kerr, J. W. Fowler, Geoffrey D. Chisholm, W. Duncan, H. Klys
Publikováno v:
British Journal of Urology. 75:38-43
Objective To assess the Results of radiotherapy in the treatment of localized prostate cancer. End points for assessment were survival, local control, development of metastases, and the toxicity of therapy. Materials and methods The case notes of 191
Publikováno v:
British Journal of Urology. 74:637-641
Objective To examine the clinical course following surveillance and symptomatic treatment, and compare the outcomes of immediate and delayed hormonal treatment in men with locally advanced prostatic cancer. Patients and methods Of a consecutive serie
Publikováno v:
British Journal of Urology. 73:683-686
Objective To identify the various presenting symptoms in patients with metastatic prostate cancer, quantify the metastatic load for each symptom group and compare their case-specific survival. Patients and methods A prospective and consecutive series
Publikováno v:
British Journal of Urology. 72:933-936
Summary The different patterns of bone metastasis, metastatic load and their prognostic significance were examined in a consecutive series of 169 men with prostatic cancer and bone metastasis at presentation. Patients with an isolated metastasis in t
Publikováno v:
Europe PubMed Central
We have studied the Major Histocompatibility Class II-modulating and antiproliferative actions of recombinant interferon-gamma, tumor necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and granulocyte macrophage-colony stimulating factor on bl
Publikováno v:
British Journal of Urology. 71:716-720
Recent studies have shown an increased late mortality rate due to cardiovascular causes after transurethral compared with open prostatectomy. This has been linked to the demonstration of haemodynamic changes during transurethral prostatectomy, which